Effect of curcumin on irradiated and estrogen-transformed human breast cell lines.

Curcumin (diferuloyl methane) is a well known antioxidant that exerts antiproliferative and apoptotic effects. Curcumin effect was evaluated in a breast cancer model that was developed using the immortalized breast epithelial cell line MCF-10F after exposure to low doses of high LET (linear energy transfer) α particles (150 keV/µm) of radiation, and subsequently cultured in the presence of 17β-estradiol (estrogen). This model consisted of human breast epithelial cells in different stages of transformation: i) MCF-10F; ii) Estrogen cell line; iii) a malignant Alpha3 cell line; iv) a malignant and tumorigenic, Alpha5 cell line; and v) a cell line derived from Alpha5 injected into the nude mice that gave rise to Tumor2 cell line. Curcumin decreased anchorage-independent growh in transformed breast cancer cell lines in comparison to their counterparts and increased the percentage of cells from G₀/G₁ with a concomitant increase in G₂/M phases, as well as a decrease in PCNA and Rho-A protein expression. Among the oncogenes, c-Ha-Ras and Ras homologous A (Rho-A) are important cell signaling factors for malignant transformation and to reach their active GTP bound state, Ras proteins must first release bound GDP mediated by a guanine nucleotide releasing factor (GRF). Then curcumin decrease RasGRF1 protein expression in malignant cell lines. Further, differential expression levels of cleaved (ADP) ribose polymerase 1 (PARP-1) and phosphorylated histone H2AX (γ-H2AX) were observed after curcumin treatment. It seems that PARP-1 similar to H2AX, confers cellular protection against radiation and estrogen-induced DNA damage mediated by curcumin. Therefore, targeting either PARP-1 or H2AX may provide an effective way of maximizing the therapeutic value of antioxidants for cancer prevention.

[1]  J. Kirkland.  Poly ADP-ribose polymerase-1 and health , 2010, Experimental biology and medicine.

[2]  D. Beer,et al.  Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. , 2010, Translational oncology.

[3]  S. Kaufmann,et al.  PARP inhibition: PARP1 and beyond , 2010, Nature Reviews Cancer.

[4]  Shun-qian Jin,et al.  The Mismatch Repair System Modulates Curcumin Sensitivity through Induction of DNA Strand Breaks and Activation of G2-M Checkpoint , 2010, Molecular Cancer Therapeutics.

[5]  A. Agarwal,et al.  Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes , 2009, Reproductive biology and endocrinology : RB&E.

[6]  Timothy J. Kinsella,et al.  Coordination of DNA Mismatch Repair and Base Excision Repair Processing of Chemotherapy and Radiation Damage for Targeting Resistant Cancers , 2009, Clinical Cancer Research.

[7]  C. Geard,et al.  Histone H2AX is a critical factor for cellular protection against DNA alkylating agents , 2008, Oncogene.

[8]  E. Schleicher,et al.  The Chemopreventive Polyphenol Curcumin Prevents Hematogenous Breast Cancer Metastases in Immunodeficient Mice , 2006, Cellular Physiology and Biochemistry.

[9]  S. Wexner,et al.  Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Zhiwei Wang,et al.  Retracted: Notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells , 2006, Cancer.

[11]  M. Hande,et al.  Allelic imbalance at 11q23-q24 chromosome associated with estrogen and radiation-induced breast cancer progression. , 2006, International journal of oncology.

[12]  Sanjeev Banerjee,et al.  Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice , 2005, Clinical Cancer Research.

[13]  Z. Khatib,et al.  Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. , 2005, Anticancer research.

[14]  T. Hei,et al.  Immunochemical analysis of protein expression in breast epithelial cells transformed by estrogens and high linear energy transfer (LET) radiation , 2005, Histochemistry and Cell Biology.

[15]  S. Pal,et al.  Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-expressed Cells at G2 Phase of Cell Cycle in a p53-dependent Manner* , 2005, Journal of Biological Chemistry.

[16]  M. Pirmohamed,et al.  Phase I Clinical Trial of Oral Curcumin , 2004, Clinical Cancer Research.

[17]  Michel Nussenzweig,et al.  H2AX: the histone guardian of the genome. , 2004, DNA repair.

[18]  Changguo Chen,et al.  Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. , 2003, The Journal of surgical research.

[19]  T. Hei,et al.  Allelic imbalance at 11p15.5–15.4 correlated with c‐Ha‐ras mutation during radiation‐induced neoplastic transformation of human breast epithelial cells , 2003, International journal of cancer.

[20]  E. Shin,et al.  c-Jun N-terminal kinase is involved in motility of endothelial cell , 2001, Experimental & Molecular Medicine.

[21]  T. Hei,et al.  Profiling of differentially expressed genes induced by high linear energy transfer radiation in breast epithelial cells , 2001, Molecular carcinogenesis.

[22]  J. Lacal,et al.  Rho signals to cell growth and apoptosis. , 2001, Cancer letters.

[23]  P. Limtrakul,et al.  Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin , 2001, BMC Cancer.

[24]  G. Hei.  Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation , 2001, International journal of radiation biology.

[25]  L. Van Aelst,et al.  Rho GTPases: signaling, migration, and invasion. , 2000, Experimental cell research.

[26]  T. Hei,et al.  Establishment of a radiation- and estrogen-induced breast cancer model. , 2000, Carcinogenesis.

[27]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[28]  P. Limtrakul,et al.  Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. , 1997, Cancer letters.

[29]  D. Spandidos,et al.  Mutations of ras genes in human tumors (review). , 1995, International journal of oncology.

[30]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[31]  J. Russo,et al.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.

[32]  J. Bos,et al.  The ras gene family and human carcinogenesis. , 1988, Mutation research.

[33]  E. Gelmann,et al.  Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Hand,et al.  ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[35]  J. Schlom,et al.  Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. , 1986, Cancer research.

[36]  R. Kuttan,et al.  Potential anticancer activity of turmeric (Curcuma longa). , 1985, Cancer letters.

[37]  Shishir,et al.  [ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY] The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease Volume 595 || REGULATION OF COX AND LOX BY CURCUMIN , 2007 .

[38]  N. Seeram,et al.  10 Curcumin — Biological and Medicinal Properties , 2006 .

[39]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[40]  A. Conney,et al.  Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. , 1991, Advances in enzyme regulation.